Received Jun 29, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RAB | RABIES (RABAVERT) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | FDP00824 | — |
Patient received only the diluent for RabAvert vaccine; Patient received only the diluent for RabAvert vaccine; Case reference number US-BN-2026-000599 is a spontaneous case initially received from other health professional via Bavarian Nordic reference number:(CASE-2026-000283) on 13-Apr-2026 and concerns a 39-years-old female patient. The patient's medical history and concomitant medication details were not provided. On an unspecified date, the healthcare professional (HCP) due to RabAvert product mishandling drew up the diluent and only the diluent was given to the patient and not the mixed product (explicitly coded as 'product preparation error', 'product administration error'). On an unspecified date, the patient received dose of RabAvert along with its constituent parts prefilled syringe, needle for injection and needle for reconstitution (batch number: FDP00824), at an unknown dose, site or route of administration for unknown indication. At the time of initial, it was unknown if the patient experienced any adverse event due to the RabAvert vaccination. Additional information received from other health professional on 14-Apr-2026: batch number added.; Reporter's Comments: This is spontaneous case, involving a 39 year old female patient. Due to product mishandling, only the diluent of RabAvert was administered on an unspecified date, coded as product preparation and administration errors. Product preparation and administration errors is expected as per company conventions. Unknown dose, site, route, and indication. medical history, and concomitant medications were all unknown. It is unclear if any adverse events occurred following vaccination. Product preparation and administration errors is not related to the suspect vaccine, but to a human factor. The case is non serious.; Sender's Comments: This is spontaneous case, involving a 39 year old female patient. Due to product mishandling, only the diluent of RabAvert was administered on an unspecified date, coded as product preparation and administration errors. Product preparation and administration errors is expected as per company conventions. Unknown dose, site, route, and indication. medical history, and concomitant medications were all unknown. It is unclear if any adverse events occurred following vaccination. Product preparation and administration errors is not related to the suspect vaccine, but to a human factor. The case is non serious.
Comments: None.